Elevated expression of the toll like receptors 2 and 4 in obese individuals: Its significance for obesity-induced inflammation

Journal of Inflammation (United Kingdom)

Volumn 9, Issue , 2012, Pages

  Ahmad, Rasheed ^a   Al Mass, Anfal ^a   Atizado, Valerie ^a   Al Hubail, Asma ^a   Al Ghimlas, Fahad ^a   Al Arouj, Monira ^a   Bennakhi, Abdullah ^a   Dermime, Said ^a   Behbehani, Kazem ^a  

^a DASMAN DIABETES INSTITUTE   (Kuwait)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; INTERLEUKIN 6; MESSENGER RNA; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; OBESITY; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 84870057394     PISSN: None     EISSN: 14769255     Source Type: Journal    
DOI: 10.1186/1476-9255-9-48     Document Type: Article

References (34)

1. Minireview: adiposity, inflammation, and atherogenesis. Lyon CJ, Law RE, Hsueh WA, Endocrinology 2003 144 2195 2200 (Pubitemid 36629866)
2. Obesity and the role of adipose tissue in inflammation and metabolism. Greenberg AS, Obin MS, Am J Clin Nutr 2006 83 461S 465S (Pubitemid 44713219)
3. Inflammation and insulin resistance. Shoelson SE, Lee J, Goldfine AB, J Clin Invest 2006 116 1793 1801 (Pubitemid 44033299)
4. Toll-like receptors expression and signaling in glia cells in neuro-amyloidogenic diseases: towards future therapeutic application. Trudler D, Farfara D, Frenkel D, Mediators Inflamm 2010 2010 1 12
5. Toll-like receptor signalling. Akira S, Takeda K, Nat Rev Immunol 2004 4 499 511 (Pubitemid 38931765)
6. TLR4 links innate immunity and fatty acid-induced insulin resistance. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS, J Clin Invest 2006 116 3015 3025 (Pubitemid 44684486)
7. Toll-like receptors and diabetes. Wong FS, Wen L, Ann N Y Acad Sci 2008 1150 123 132
8. Emerging role of Toll-like receptors in atherosclerosis. Curtiss LK, Tobias PS, J Lipid Res 2009 50 Suppl 340 S345
9. Increased toll-like receptor (TLR) 2 and TLR4 expression in monocytes from patients with type 1 diabetes: further evidence of a proinflammatory state. Devaraj S, Dasu MR, Rockwood J, Winter W, Griffen SC, Jialal I, J Clin Endocrinol Metab 2008 93 578 583 (Pubitemid 351240834)
10. Endogenous ligands of Toll-like receptors. Tsan MF, Gao B, J Leukoc Biol 2004 76 514 519 (Pubitemid 39129081)
11. Elevated toll-like receptor 4 expression and signaling in muscle from insulin-resistant subjects. Reyna SM, Ghosh S, Tantiwong P, Meka CS, Eagan P, Jenkinson CP, Cersosimo E, Defronzo RA, Coletta DK, Sriwijitkamol A, Musi N, Diabetes 2008 57 2595 2602
12. Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Creely SJ, McTernan PG, Kusminski CM, Fisher M, Da Silva NF, Khanolkar M, Evans M, Harte AL, Kumar S, Am J Physiol Endocrinol Metab 2007 292 740 E747
13. Activation of Toll-like receptor 4 is associated with insulin resistance in adipocytes. Song MJ, Kim KH, Yoon JM, Kim JB, Biochem Biophys Res Commun 2006 346 739 745
14. Adipocyte-mononuclear cell interaction, Toll-like receptor 4 activation, and high glucose synergistically up-regulate osteopontin expression via an interleukin 6-mediated mechanism. Samuvel DJ, Sundararaj KP, Li Y, Lopes-Virella MF, Huang Y, J Biol Chem 2010 285 3916 3927
15. Impaired induction of IL-15 in response to herpes simplex virus type 1 infection in peripheral blood mononuclear cells of HIV-infected patients. Ahmad A, Ahmad R, Toma E, Morisset R, Menezes J, AIDS 2000 14 744 746 (Pubitemid 30229355)
16. Study of TLR3, TLR4 and TLR9 in breast carcinomas and their association with metastasis. Gonzalez-Reyes S, Marin L, Gonzalez L, Gonzalez LO, del Casar JM, Lamelas ML, Gonzalez-Quintana JM, Vizoso FJ, BMC Cancer 2010 10 665
17. Flagellin contamination of recombinant heat shock protein 70 is responsible for its activity on T cells. Ye Z, Gan YH, J Biol Chem 2007 282 4479 4484 (Pubitemid 47100931)
18. Requirement of TLR2-mediated signaling for the induction of IL-15 gene expression in human monocytic cells by HSV-1. Ahmad R, El Bassam S, Cordeiro P, Menezes J, Blood 2008 112 2360 2368
19. The role of TNF-alpha in insulin resistance. Borst SE, Endocrine 2004 23 177 182
20. Mechanisms of TNF-alpha-induced insulin resistance. Hotamisligil GS, Exp Clin Endocrinol Diabetes 1999 107 119 125
21. Interleukin-6 induces cellular insulin resistance in hepatocytes. Senn JJ, Klover PJ, Nowak IA, Mooney RA, Diabetes 2002 51 3391 3399 (Pubitemid 35403441)
22. Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice. Klover PJ, Zimmers TA, Koniaris LG, Mooney RA, Diabetes 2003 52 2784 2789 (Pubitemid 37339708)
23. Toll-like receptors. Takeda K, Kaisho T, Akira S, Annu Rev Immunol 2003 21 335 376 (Pubitemid 37174535)
24. Increased toll-like receptor activity in patients with metabolic syndrome. Jialal I, Huet BA, Kaur H, Chien A, Devaraj S, Diabetes Care 2012 35 900 904
25. Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation. Edfeldt K, Swedenborg J, Hansson GK, Yan ZQ, Circulation 2002 105 1158 1161 (Pubitemid 34225814)
26. Overexpression of toll-like receptors 3 and 4 in synovial tissue from patients with early rheumatoid arthritis: toll-like receptor expression in early and longstanding arthritis. Ospelt C, Brentano F, Rengel Y, Stanczyk J, Kolling C, Tak PP, Gay RE, Gay S, Kyburz D, Arthritis Rheum 2008 58 3684 3692
27. Macrophage infiltration into omental versus subcutaneous fat across different populations: effect of regional adiposity and the comorbidities of obesity. Harman-Boehm I, Bluher M, Redel H, Sion-Vardy N, Ovadia S, Avinoach E, Shai I, Kloting N, Stumvoll M, Bashan N, Rudich A, J Clin Endocrinol Metab 2007 92 2240 2247 (Pubitemid 46997129)
28. Inflammatory role of Toll-like receptors in human and murine adipose tissue. Poulain-Godefroy O, Le Bacquer O, Plancq P, Lecoeur C, Pattou F, Fruhbeck G, Froguel P, Mediators Inflamm 2010 2010 823486
29. Plasma free fatty acid concentrations in obesity. Opie LH, Walfish PG, N Engl J Med 1963 268 757 760
30. Increased toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects. Dasu MR, Devaraj S, Park S, Jialal I, Diabetes Care 2010 33 861 868
31. Resistin competes with lipopolysaccharide for binding to toll-like receptor 4. Tarkowski A, Bjersing J, Shestakov A, Bokarewa MI, J Cell Mol Med 2010 14 1419 1431
32. Endogenous TLR ligands and autoimmunity. Wagner H, Adv Immunol 2006 91 159 173 (Pubitemid 44286996)
33. Tlr2 is critical for diet-induced metabolic syndrome in a murine model. Himes RW, Smith CW, FASEB J 2010 24 731 739
34. Toll-like receptor 2 deficiency improves insulin sensitivity and hepatic insulin signalling in the mouse. Kuo LH, Tsai PJ, Jiang MJ, Chuang YL, Yu L, Lai KT, Tsai YS, Diabetologia 2011 54 168 179